Right, let’s be honest. We all chase the whispers, don’t we? The analyst upgrades, the “strong buy” recommendations… it’s less about fundamental value and more about a collective decision to believe in something. And Monday? Monday was all about Edgewise Therapeutics. Their stock jumped 4% – which, in this market, feels almost… indecently optimistic. Crushed the S&P 500, apparently. Honestly, the S&P is just showing off at this point.
The Rahimi Effect
The source of this little surge? Yasmeen Rahimi over at Piper Sandler. She’s been a fan for a while, which, in my experience, usually means she’s either genuinely brilliant or has a vested interest. (It’s rarely just altruism, darling.) She reiterated her “overweight” rating, slapped a $51 price target on it, and suddenly, everyone decided Edgewise was the next big thing. I mean, it’s a bit dramatic, isn’t it? Like we’re all waiting for a sign.
Apparently, Rahimi considers it one of Piper Sandler’s top picks this year. That’s… bold. It all hinges on EDG-7500, their cardiovascular drug candidate for hypertrophic cardiomyopathy. HCM, for those of us who didn’t spend our childhood memorizing medical terms. It’s a genetic heart condition, and EDG-7500 is supposed to be… different. Innovative. The buzzwords are flying already. Phase 2 trial results are due in the second quarter, and that’s when the real fun begins. Or the real panic. It’s always one or the other.
More Than Just a Heartbeat
But it’s not just about the heart, is it? (Though, let’s face it, a failing heart is a pretty compelling narrative.) Rahimi also points to other programs in their pipeline, and I have to admit, they’re doing some interesting work. Sevasemten, a muscular dystrophy treatment, is looking promising, and diversification is always a good thing. Unless, of course, it’s a smokescreen. You have to be cynical, it’s a survival mechanism. I’m just saying.
Look, I’m not saying it’s a sure thing. Nothing is. But there’s a definite energy around this stock. And in this market, sometimes that’s enough. Sometimes, you just have to ride the wave, even if you suspect it’s heading straight for the rocks. It’s a calculated risk, obviously. And I’m a professional. (Mostly.)
Read More
- 20 Movies Where the Black Villain Was Secretly the Most Popular Character
- Top 20 Dinosaur Movies, Ranked
- 25 “Woke” Films That Used Black Trauma to Humanize White Leads
- Silver Rate Forecast
- Gold Rate Forecast
- 22 Films Where the White Protagonist Is Canonically the Sidekick to a Black Lead
- Can AI Lie with a Picture? Detecting Deception in Multimodal Models
- Top 10 Coolest Things About Invincible (Mark Grayson)
- When AI Teams Cheat: Lessons from Human Collusion
- From Bids to Best Policies: Smarter Auto-Bidding with Generative AI
2026-02-10 04:12